Two Sigma Securities’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,800
Closed -$207K 2577
2024
Q3
$207K Sell
10,800
-12,700
-54% -$245K ﹤0.01% 2125
2024
Q2
$513K Buy
+23,500
New +$626K 0.01% 1519
2023
Q4
Sell
-3,900
Closed -$292K 3367
2023
Q3
$292K Sell
3,900
-800
-17% -$71K ﹤0.01% 1987
2023
Q2
$433K Sell
4,700
-700
-13% -$62.3K 0.01% 1542
2023
Q1
$560K Buy
5,400
+900
+20% +$99.7K 0.01% 1190
2022
Q4
$519K Sell
4,500
-8,000
-64% -$932K 0.02% 1060
2022
Q3
$1.35M Buy
12,500
+8,500
+213% +$1.22M 0.04% 505
2022
Q2
$722K Buy
+4,000
New +$716K 0.03% 697

Other funds holding MED

Two Sigma Securities's MED Position: Q1 2024 in Review

Two Sigma Securities sold out of Medifast (MED) in Q1 2024, closing a stake of 3,673 shares — an estimated $247K sold.

Two Sigma Securities first reported a position in MED in Q1 2022 and held it in 4 quarters. The position peaked at $359K in Q4 2022. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • Two Sigma Securities reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Securities sold 3,673 Medifast shares in Q1 2024, an estimated $247K.
  • Two Sigma Securities first reported a position in Medifast in Q1 2022 and held it in 4 quarters.
  • Two Sigma Securities's Medifast position peaked at $359K in Q4 2022.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.